We participate in all phases of engineering:
I+Med has state-of-the-art facilities for polymer research, formulation development, analytical and manufacturing activities.
I+Med’s infrastructure enables support of partners not only during the first feasibility phase, but also during all subsequent product development phases, all the way up to manufacturing and supply of animal trial and clinical trial (GMP) batches and technology transfer if required. Regulatory support and quality assurance form an integral part of the product development services.
Over the past years, i+Med has gathered extensive pre-clinical (including animal trials) data, allowing for an efficient and fast product development track. This in turn helps us perform clinical trials in a timely manner.